ACTA1 and diabetes mellitus: Our results showed that treatment with the TM compounds inhibited STZ-induced upregulation of collagen I (Fig 2A), fibronectin (Fig 2B), and α-SMA (Fig 2C) mRNAs in diabetic kidneys.